Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults

NCT01014806 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

467

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza VLP Vaccine
BIOLOGICAL: TIV

Sponsor

Novavax